Immunoassay analyzers are used to identify and detect the concentration of specific substances in patient samples, usually using an antibody as a reagent. These devices are used in hospitals and clinical laboratories to perform a variety of tests including cancer, hormonology, serology, therapeutic drug monitoring and more. Beckman Coulter offers a variety of scalable immunoassay analyzers, which can help optimize your laboratory’s uptime, reliability and performance.
Access BNP reflects cardiac status and effects of therapy Access BNP joins other Beckman Coulter cardiovascular diseases (CVD) assays, such as Access hsTnI, the first FDA-approved high sensitivity troponin I assay, AccuTnI+3 (Troponin I), CK-MB (Creatine Kinase MB), Myoglobin and Digoxin. “BNP is a protein secreted by the ventricular musculature in response to volume or pressure overload on the heart. This is an important biomarker in the diagnosis of heart failure (HF)iii and left ventricular dysfunction” said Dr.Anagh Vora, chief medical officer, Beckman Coulter. This high-performance assay can be used across all Beckman Coulter immunoassay analyzers, including, Access 2, DxI 600 and DxI 800 LEARN MORE
In general virus infection behavior, an IgM assay will give information about current or recent infection; while IgG will, in addition, also give information about a more sustainable immune response.These two pieces of the infection story blur together when the patient takes a combined, or total IgM and IgG test. Because seroconversion is such a highly individualized journey, separate SARS-CoV-2 IgM and IgG tests can provide greater insight into where the patient is at in their infection timeline
Exceptional productivity in a compact design Reliability matters. This benchtop immunoassay analyzer fits labs with space constraints and delivers fast, reliable results. Learn more